Listen
Archive
2013
January
February
March
April
May
June
2012
January
February
March
April
May
June
July
August
September
October
November
December
2011
January
February
March
April
May
June
July
August
September
October
November
December
2010
January
February
March
April
May
June
July
August
September
October
November
December
2009
January
February
March
April
May
June
July
August
September
October
November
December
2008
January
February
March
April
May
June
July
August
September
October
November
December
2007
June
July
August
September
October
November
December
Subscribe
Dec. 11, 2009
Gene Patenting
Click 
to enlarge images
to enlarge images
|
|
Tweet |
|
A case currently in federal court questions whether it should be possible to patent genetic sequences. At issue is whether Utah-based Myriad Genetics, a biotech company, should be allowed to hold patents on genes known as BRCA1 and BRCA2, which are linked to increased risk of developing breast cancer. Although courts have held that "products of nature" and "laws of nature" are not patentable, the US Patent Office has been awarding patents involving genetic sequences for over 20 years. Currently, thousands of genetic sequences have been patented. In May of this year, the ACLU organized a lawsuit, Association For Molecular Pathology et al v. United States Patent and Trademark Office et al, seeking to have the Myriad patents thrown out. Part of their argument centers on the US Constitution, which gives Congress power "to promote the progress of science and useful arts, by securing for limited times to authors and inventors the exclusive right to their respective writings and discoveries." Because the gene patents hinder scientific progress, the lawsuit argues, the Patent and Trademark Office acted against the Constitution in granting those patents. We'll talk about the case, and the arguments on both sides of the issue. |
Produced by Annette Heist, Senior Producer
Guests
-
Kevin Noonan
Patent Attorney, Molecular Biologist
Partner, McDonnell, Boehnen, Hulbert & Berghoff, LLP
Chicago, Illinois -
Daniel Ravicher
Executive Director, Public Patent Foundation
Lecturer in Law and Associate Director of the Intellectual Property Law Program
Benjamin N. Cardozo School of Law
New York, New York
FEATURED READING
Scatter, Adapt, and Remember: How Humans Will Survive a Mass Extinction
by Annalee Newitz
ADVERTISEMENT
RELATED BLOG POSTS
- Their World Is Oysters
A trip to a shellfish hatchery in Washington reveals a bustling operation.
- Angry Legos, Roman Wonder Concrete, Beating Boredom, and More
Each week we’ll round up links to science stories or studies that blow our mind, tickle our funny bone, or generally strike our ...
- Building the Space Needle
How a sketch on a placemat became a symbol for Seattle.
- Mars Road Trip, Bird Penises (or Lack Thereof), and More
Each week we’ll round up links to science stories or studies that blow our mind, tickle our funny bone, or generally strike our ...
Discussion